SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
  
 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Daniel Christopher F
(Last) (First) (Middle)
C/O DESTINATION MATERNITY CORPORATION
456 NORTH FIFTH STREET
(Street)
PHILADELPHIA PA 19123
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Destination Maternity Corp [ DEST ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
President
3. Date of Earliest Transaction (Month/Day/Year)
11/16/2013
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 11/16/2013 F 360(1) D $32.04 14,488(2) D
Common Stock 11/18/2013 F 167(3) D $31.99 14,321(2) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Options (Right to Buy) $20.62 (4) 06/01/2021 Common Stock 40,000 40,000 D
Stock Options (Right to Buy) $14.51 (5) 11/18/2021 Common Stock 3,755 3,755 D
Stock Options (Right to Buy) $19.89 (6) 11/16/2022 Common Stock 11,615 11,615 D
Explanation of Responses:
1. 360 shares were surrendered to the Issuer to pay applicable tax withholdings on the November 16, 2013 vest of 1,178 shares from the November 16, 2012 grant of 4,713 shares.
2. Includes 6,000 shares of unvested restricted stock from the June 1, 2011 grant of 10,000 shares, which shares vest in equal annual installments over a five (5) year period beginning on June 1, 2012, 1,094 shares of unvested restricted stock from the November 18, 2011 grant of 2,188 shares, which shares vest in equal annual installments over a four (4) year period beginning on November 18, 2012, and 3,535 shares of unvested restricted stock from the November 16, 2012 grant of 4,713 shares, which shares vest in annual installments over a four (4) year period beginning on November 16, 2013 as follows: 1,178 shares vest on each of November 16, 2013, November 16, 2014, and November 16, 2015, and 1,179 shares vest on November 16, 2016.
3. 167 shares were surrendered to the Issuer to pay applicable tax withholdings on the November 18, 2013 vest of 547 shares from the November 18, 2011 grant of 2,188 shares.
4. On June 1, 2011, options to purchase 40,000 shares were granted to the Reporting Person by the Issuer. The options vest and are exercisable in five (5) equal annual installments beginning on June 1, 2012. 16,000 of the June 1, 2011 options are vested and 24,000 are unvested.
5. On November 18, 2011, options to purchase 5,006 shares were granted to the Reporting Person by the Issuer. The options vest and are exercisable in four (4) annual installments beginning on November 18, 2012 as follows: 1,251 options vest on each of November 18, 2012 and November 18, 2014, and 1,252 options vest on each of November 18, 2013 and November 18, 2015. Of the remaining 3,755 November 18, 2011 options, 1,252 are vested and 2,503 are unvested.
6. On November 16, 2012, options to purchase 11,615 shares were granted to the Reporting Person by the Issuer. The options vest and are exercisable in four (4) annual installments beginning on November 16, 2013 as follows: 2,903 options vest on November 16, 2013, and 2,904 options vest on each of November 16, 2014, November 16, 2015, and November 16, 2016. 2,903 of the November 16, 2012 options are vested and 8,712 are unvested.
Christopher F. Daniel 11/19/2013
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.